For example, a polymorphism of inhibitory receptor FcγRIIb protects individuals against malaria but increases susceptibility to systemic lupus erythematosus (SLE) [54–56] and the occurrence of HIV infections in SLE patients is disproportionately low [31–33]. This evidence concerns the gene FCGR2B and malaria.